Overview
Share price change
24h
Current
Min
1.17
Max
1.3900000000000001
Income | -202K -5.7M |
|---|---|
EPS | -0.47 |
EBITDA | -219K -4.6M |
Next Earnings | 28 Dec 2026 |
|---|
Market Cap | -3M 23M |
|---|---|
Previous open | 1.35 |
Previous close | 1.35 |
CEL-SCI Corp Chart
Past performance is not a reliable indicator of future results.
Related News
3 Nov 2026, 23:56 UTC
Taco Bell's U.S. sales show signs of recovery after outbreak.
Read
3 Nov 2026, 23:56 UTC
GXO Logistics reported Q3 net income of $65 million and adjusted EPS of $0.89, exceeding expectations, but operating income fell to $96 million.
Read
3 Nov 2026, 23:51 UTC
Palantir Technologies reported better-than-expected Q3 2026 earnings and revenue, but shares declined amid concerns over total growth slowdown.
Read
3 Nov 2026, 23:51 UTC
MercadoLibre shares are trading modestly higher in after-market hours ahead of its third quarter earnings report on November 4.
Read
3 Nov 2026, 23:51 UTC
USD/PLN declines, breaking a trend of higher daily closes, amid strong U.S. economic indicators including increased JOLTs Job Openings and Factory Orders.
Read
3 Nov 2026, 23:51 UTC
USD/SGD is slightly higher as U.S. durable goods orders held at 0.5%, JOLTs Job Openings rose to 7.523 million, and Factory Orders increased by 1.8%.
Read
3 Nov 2026, 23:51 UTC
The USD/DKK is declining, breaking a trend of higher daily closes, despite U.S. durable goods orders meeting expectations at 0.5% for September.
Read
3 Nov 2026, 23:51 UTC
USD/NOK currency pair declines, influenced by September's JOLTs Job Openings report exceeding expectations and strong Factory Orders, while remaining below its 20-day moving average.
Read
3 Nov 2026, 23:46 UTC
AtriCure reports Q3 2026 revenue of $154.5 million and raises full-year adjusted EPS guidance to $0.40-$0.46, despite a decline in after-market trading.
Read
3 Nov 2026, 23:46 UTC
Exelixis to participate in investor conferences on November 10 and 11, showcasing advancements in oncology and its drug pipeline.
Read
3 Nov 2026, 23:46 UTC
Supernus Pharmaceuticals, Inc. shares are trading modestly lower in after-market hours following its merger with Indivior and orphan drug exclusivity for ONAPGO.
Read
3 Nov 2026, 23:41 UTC
Cisco Systems schedules a conference call for November 12, 2026, at 1:30 PM PT to discuss its Q1 fiscal year 2027 financial results.
Read
3 Nov 2026, 23:41 UTC
Meta Platforms, Inc. priced its $15 billion bond sale, attracting orders of up to $58 billion, while over 10 million users activated its Muse agents.
Read
3 Nov 2026, 23:31 UTC
Innospec Inc. reported Q3 earnings of $1.29 per share, exceeding expectations, but missed revenue forecasts with sales of $473.6 million.
Read
3 Nov 2026, 23:31 UTC
Cytokinetics to participate in November investor conferences and plans to submit a Supplemental New Drug Application for aficamten in Q4 2026.
Read
3 Nov 2026, 23:31 UTC
CrowdStrike launches its AI agent "Kill Switch" and plans to acquire Fiddler AI for approximately $400 million to enhance AI monitoring capabilities.
Read
3 Nov 2026, 23:31 UTC
Ternium SA reported Q3 EPS of $1.42, below estimates, with revenue of $4.64 billion; shares advanced in after-market trading following the earnings report.
Read
3 Nov 2026, 23:31 UTC
Sterling Infrastructure, Inc. is trading higher in after-market hours, supported by strong economic indicators and the upward trend in the iShares Semiconductor ETF (SOXX).
Read
3 Nov 2026, 23:21 UTC
Citi analyst Pat Cunningham raised DuPont's price target to $176.00 from $162.00 while maintaining a Buy rating, reflecting increased confidence in the company's outlook.
Read
3 Nov 2026, 23:21 UTC
Twist Bioscience announces a proposed derivative settlement with governance reforms and $1 million in legal fees, pending court approval.
Read
3 Nov 2026, 23:21 UTC
International Flavors & Fragrances Inc. reported a third-quarter loss of $55 million and raised full-year revenue guidance, which fell short of analyst expectations.
Read
3 Nov 2026, 23:11 UTC
Essential Utilities reports Q3 GAAP EPS of $0.36 and adjusted EPS of $0.38, with revenue of $508.3 million, missing estimates of $567.31 million.
Read
3 Nov 2026, 23:11 UTC
American International Group, Inc. reported a third-quarter profit of $844 million, exceeding estimates, and declared a quarterly cash dividend of $0.50 per share.
Read
3 Nov 2026, 23:06 UTC
Apollo Global Management is seeing a modest increase in after-market trading, bolstered by record lending of $114 billion driven by AI funding initiatives.
Read
3 Nov 2026, 23:06 UTC
American Electric Power launches AEP Infrastructure to enhance energy development, led by Greg Hall, while Jacobs joins for project management on a $37 billion modernization program.
Read
3 Nov 2026, 23:06 UTC
Micron Technology, Inc. sees a favorable market response due to strong demand for AI infrastructure boosting its memory-chip business amid industry growth.
Read
3 Nov 2026, 23:06 UTC
Amdocs has announced a dispute with T-Mobile US, alleging breaches of agreements, which may affect T-Mobile's operational stability and future performance.
Read
3 Nov 2026, 23:06 UTC
Apple Inc. shares declined after the company warned of potential profit margin pressures due to rising memory chip costs, despite broader market gains.
Read
3 Nov 2026, 23:06 UTC
Lockheed Martin awarded a task order worth up to $80 million for software support on the Strategic Mission Planning and Execution System, expected to complete by January 2030.
Read
3 Nov 2026, 23:06 UTC
Citi's Geoff Meacham raises Pfizer's price target to $30.00 while the company appoints Cecile Guegan as CFO with a $1.30 million salary.
Read
Peer Comparison
Price change
CEL-SCI Corp Forecast
Rating Consensus
By TipRanks
0 ratings
0
Buy
0
Hold
0
Sell
Based on 0 analysts giving stock ratings to CEL-SCI Corp - Dist in the past 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$